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The antibiotic oligomycin has been demonstrated 
by Lardy et al. [ 1] .to act as a potent inhibitor of 
oxidative phosphorylation. As the first specific in- 
hibitor acting at the site of coupling between res- 
piration and phosphorylation, oligomycin has become 
a most valuable tool for investigating the mechanism 
of this process, and has as such been widely used 
over the past years in studies with mitochondria [2], 
submitochondrial particles [3] and purified enzymes 
[4] . Its precise mode of action, however, has not 
yet been understood, and progress to this end has 
been seriously limited by the lack of knowledge 
of the structure of oligomycin. 
Preparations of oligomycin contain 3 molecular 
species, denoted A, B and C, which all inhibit oxi- 
dative phosphorylation with equal efficiencies [5] . 
By chemical studies of degradation products of 
purified oligomycin B, parts of its structure have 
been determined by Prouty et al, [6]. These studies 
have indicated that the molecule, with an observed 
chemical composition C4sHn 01*, consists of a large, 
25- or 26-membered, heterocyclic ring containing 
3 double-bonds. The ring also contains keto, hydroxy 
and methyl substituents, and is linked to 2 saturated, 
hetero-atomic, 6-membered rings. 
The present paper reports the three-dimensional 
structure of oligomycin B, as determined from single- 
crystal X-ray diffraction data. 
North-Holland Publishing Company-Amsterdinn 
2. Materials and methods 
Oligomycin B was separated from a commercially 
available preparation of oligomycins A and B (Sigma 
Chemical Company, St. Louis, MO., USA) by thin 
layer chromatography. Crystals were obtained by 
slow evaporation of methanolic solutions of the 
compound. Single-crystal X-ray diffraction data 
were collected on a diffractometer (Siemens) with 
monochromatized CL&~ radiation. 
3. Results and discussion 
The dimensions of the unit cell agree reasonably 
well with those reported by Masamune et al. [7] for 
single crystals of oligomycin B prepared from metha- 
nolic solutions as shown in table 1. Because of the 
lack of atoms heavier than oxygen in the molecule, 
and also of the lack of knowledge, of the total chemi- 
cal structure, direct methods for phase-determination 
(cf. [S]) were applied, with the assumption that the 
molecule consisted of 57 nonhydrogen atoms. Some 
difficulties were encountered during the initial appli- 
cations of direct methods, due to comparatively bad 
choices of the basis sets. These problems were satis- 
factorily solved when applying a more systematic 
choice of basis set as described by Norrestam [9]. 
The phases obtained were refined by using variance- 
weighted [9] Z2 formulas [8] . The 11 highest, 
chemically meaningful peaks in the calculated elec- 
tron-density map (E map) were accepted and used to 
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Table 1 
Comparison of unit cell parameters of oligomycin B 
(space-group P2r 2121) obtained in the present study 
with those given by Masamune t aL [ 71. 
Parameter Resent study 
(It\) 
Masamume t al. 
(A) 
..m 
a 10.33 10.25 
b 17.38 16.92 
C 26.99 26.34 
obtain estimates of phases to be included in a new 
basis set. After 2 such phase refmements using partial 
structure information, the subsequent E map showed 
24 reasonable atomic positions. The positions of the 
remaining nonhydrogen atoms were determined by 
conventional analysis of difference electron densities 
and by least-squares refinements. In all, 60 nonhydro- 
gen positions were found per asymmetric unit. Three 
of these seem to originate from water and/or methanol 
molecules, linked by hydrogen-bonding to the remain- 
ing 57 nor-hydrogen atoms, which constitute one 
molecule of oligomycin B. Least-squares refinement 
of the structural parameters for the 60 nonhydrogen 
atoms (assuming isotropical thermal vibrations) yielded 
a conventional crystallographic R value of 0.13 for the 
3 160 reflections used. A detailed description of the 
structure determination and a more elaborate discus- 
sion of the crystal structure will be published else- 
where [lo]. 
a 0 4j; 0 0 0 0 0 
Fig. 1. Schematic structural formula of oligomycin B, as 
indicated by the present X-ray study. 
which for biochemical implications is quite obvious. 
However, a thorough investigation of the hydrogen 
bonds requires knowledge of all the 76 hydrogen 
positions. Probably the quality of the data collected 
will permit a future location of most of the hydrogens. 
Details of the hydrogen-bond scheme will be given 
A comparison of the intramolecular distances and 
angles with standard values [ 1 l] indicate the schemat- 
ic formula shown in fig. 1. The assignment of the oxy- 
gens was also reasonably consistent with the thermal 
parameters obtained in a least-squares refinement 
where all atoms were treated as carbons. As seen in 
fig. 1, the oligomycin B molecule consists of a large, 
26-membered ring. Attached to this ring are a number 
of ethyl, methyl, keto and hydroxyl groups, and con- 
densed to it is a substituted tetrahydropyran ring 
which in turn is linked to another tetrahydropyran 
ring by a Spiro-junction. The conformation of the 
molecule, which is shown in fig. 2, indicates, inter 
ah, that the 2 tetrahydropyran rings both occur in 
the chair conformation. 
The large number of proper hydrogen-bond donors Fig. 2. Molecular conformation in the crystal structure of 
and acceptors within the molecule gives rise to an ex- oligomycin B. The thicker large circles denote oxygen atoms 
tensive hydrogen-bond scheme, the importance of and the smaller circles carbon atoms. 
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elsewhere [lo] . 
Acknowledgements 
This work was supported by the Swedish Natural 
Science Research Council. 
References 
[l] H.A. Lardy, D. Johnson and W.C. McMurray, Arch. 
B&hem. Biophys. 78 (1958) 587. 
[2] F. Huijing and E.C. Slater, J. Biochem. (Japan) 49 
(1961) 493. 
[3] C.P. Lee and L. Ernster, European J. Biochem. 3 (1968) 
391. 
[4] A. Tzagoloff, K.H. Byington and D.H. MacLennan, 
J. Biol. Chem. 243 (1968) 2405. 
[S] H.A. Lardy, P. Witonsky and D. Johnson, Biochemistry 
4 (1965) 552. 
[6] W.F. Prouty, R.M. Thompson, H.K. Schnoes and F.M. 
Strong, Biochem. Biophys. Res. Commun. 44 (1971) 
619; W.F. Prouty, Thesis, University of Wisconsin, 1971. 
[ 71 S. Masamune, J.M. Sehgal, E.E. Van Tamelen, F.M. 
Strong and W.H. Peterson, J.Am. Chem. Sot. 80 (1958) 
6092. 
[8] J. Karle and 1.L. Karle, Acta Cryst. 21 (1966) 849. 
[9] R. Norrestam, Acta Cryst. A 28 (1972) in press. 
[lo] R. Norrestam and M. von Glehn, to be published. 
[ 111 L.E. Sutton, Tables of Interatomic Distances and Con- 
figuration of Molecules and Ions (The Chemical SOCietY, 
London, 1958). 
269 
